AIM
SCMP

Alambic Investment Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Alambic Investment Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-101,800
Closed -$1.83M – 564
2017
Q4 		$1.83M Buy
101,800
+83,400
+453% +$1.03M 0.22% 159
2017
Q3 		$217K Buy
+18,400
New +$206K 0.02% 439

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Alambic Investment Management's SCMP Position: Q1 2018 in Review

Alambic Investment Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 101,800 shares — an estimated $1.83M sold.

Alambic Investment Management first reported a position in SCMP in Q3 2017 and held it in 2 quarters. The position peaked at $1.83M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Alambic Investment Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Alambic Investment Management sold 101,800 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.83M.
  • Alambic Investment Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2017 and held it in 2 quarters.
  • Alambic Investment Management's Sucampo Pharmaceuticals, Inc. position peaked at $1.83M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Alambic Investment Management's 13F filing for Q1 2018, filed 8 May 2018.